Evidence map›Paper›PMID 38941655›Full record

Trial reportBreast (Edinburgh, Scotland)2024

Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer-A prospective, randomized trial.

Christine Brunner, Miriam Emmelheinz, Daniel Egle, Magdalena Ritter, Katharina Leitner, Verena Wieser, Carmen Albertini, Samira Abdel Azim, Irene Mutz-Dehbalaie, Johanna Kögl and 1 more

Abstract readRandomized Controlled TrialEquivalence Trial
In one paragraph

Trial report in Breast (Edinburgh, Scotland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Addressing the Needs of Breast Cancer Survivors.Current oncology reports · 2025
    Review
  7. Regional limb cooling for the prevention of chemotherapy-induced toxicities: a narrative review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christine BrunnerDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: c.brunner@tirol-kliniken.at.
Miriam EmmelheinzDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Daniel EgleDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Magdalena RitterDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Katharina LeitnerDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Verena WieserDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Carmen AlbertiniDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Samira Abdel AzimDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Irene Mutz-DehbalaieDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Johanna KöglDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Christian MarthDepartment of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to demonstrate the superiority of cryocompression over cryotherapy alone in the prevention of chemotherapy-induced peripheral neuropathy (CIPN) grade 2 or above.

methodsThis prospective randomized study was conducted between May 2020 and January 2023 in Innsbruck. Eligible patients had a diagnosis of gynecological cancer and received a minimum of 3 cycles of taxane-based CT (neoadjuvant, adjuvant or palliative therapy). Patients were randomized 1:1 to receive either cryotherapy or cryocompression on their upper extremities during chemotherapy (CT). We performed temperature measurements, two QoL questionnaires and neurological tests during CT and at follow-up 3 and 6-9 months after the completion of CT. CIPN was assessed using the CTCAE score.

resultsOf 200 patients recruited, both groups showed a lower prevalence of CIPN in this study compared to recent literature. In the group receiving cryotherapy, the prevalence of grade 1 CIPN was 30.1 %, and that of grade 2 CIPN or above was 13.7 %; in the group treated with cryocompression, the prevalence of grade 1 CIPN was 32.8 %, and that of grade 2 or above CIPN was 17.2 %. We found a significant reduction in temperature in the cryotherapy and cryocompression groups. Regarding the two QOL questionnaires as well as the neurological tests no significant differences were found between the two groups.

conclusionOur study suggests that cryotherapy as well as cryocompression is a safe and effective way to cool patients' extremities to lower the prevalence of CIPN. Cryocompression was not more effective than cryotherapy alone in the prevention of CIPN.

Indexed as

Breast NeoplasmsCryotherapyGenital Neoplasms, FemalePeripheral Nervous System DiseasesAdultAgedAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBridged-Ring CompoundsFemaleHumansMiddle AgedProspective StudiesQuality of LifeTaxoidsTreatment OutcomeAntineoplastic AgentsBridged-Ring CompoundstaxaneTaxoidsBreast cancerChemotherapyChemotherapy-induced peripheral neuropathyCryocompressionCryotherapy

Identifiers

PMID38941655
PMCPMC11260371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.